Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Altimmune, Inc. (ALT) had Income from Continuous Operations of $-22.15M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.01M |
|
$-22.15M |
|
-- |
|
$0.01M |
|
$22.93M |
|
$-22.92M |
|
$0.78M |
|
$-22.15M |
|
$-22.15M |
|
$-22.15M |
|
|
Income from Continuous Operations |
$-22.15M |
$-22.15M |
|
$-22.15M |
|
$-22.92M |
|
$-23.27M |
|
81.48M |
|
81.48M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$188.42M |
|
$0.36M |
|
$1.93M |
|
$190.35M |
|
$9.22M |
|
$14.33M |
|
$19.76M |
|
$28.98M |
|
$161.37M |
|
$161.37M |
|
$161.37M |
|
85.08M |
|
| Cash Flow Statement Financials | |
$-36.19M |
|
$96.01M |
|
$86.36M |
|
$36.97M |
|
$183.15M |
|
$146.18M |
|
$7.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.44 |
|
-- |
|
-- |
|
0.08 |
|
0.09 |
|
100.00% |
|
-458440.00% |
|
-458440.00% |
|
-- |
|
-442920.00% |
|
-442920.00% |
|
$-36.20M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.01 |
|
0.02M |
|
-13.72% |
|
-13.72% |
|
-11.63% |
|
-12.60% |
|
$1.90 |
|
$-0.44 |
|
$-0.44 |
|